We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Cimzia Had First REMS, Then FDA Required Them for All TNF Blockers
Cimzia Had First REMS, Then FDA Required Them for All TNF Blockers
October 5, 2010
Cimzia is a tumor necrosis factor (TNF) blocker used to treat patients with Crohn’s disease. The BLA for Cimzia submitted by UCB, was approved in April 2008.